Boston Common Asset Management LLC Raises Stock Position in Xylem Inc. $XYL

Key Points

• Boston Common Asset Management increased its Xylem stake by 7.5% in the first quarter, buying 10,119 more shares and bringing its total holdings to 145,639 shares worth about $17.4 million.
• Institutional interest in Xylem remains strong, with several other hedge funds making notable moves and 87.96% of the stock now held by hedge funds and other institutional investors.
• Xylem reported solid quarterly results, topping earnings and revenue estimates, while analysts maintain a Moderate Buy consensus with an average price target of $153.31.

Boston Common Asset Management LLC lifted its holdings in Xylem Inc. (NYSE:XYL - Free Report) by 7.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 145,639 shares of the industrial products company's stock after buying an additional 10,119 shares during the period. Xylem comprises 1.1% of Boston Common Asset Management LLC's holdings, making the stock its 23rd largest holding. Boston Common Asset Management LLC owned approximately 0.06% of Xylem worth $17,404,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in XYL. Callahan Advisors LLC purchased a new position in shares of Xylem in the 4th quarter worth approximately $1,721,000. Northwestern Mutual Wealth Management Co. raised its holdings in Xylem by 2,309.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company's stock valued at $54,314,000 after buying an additional 413,904 shares during the period. Abacus Wealth Partners LLC bought a new stake in Xylem in the fourth quarter worth $1,663,000. Norges Bank bought a new stake in Xylem in the fourth quarter worth $361,012,000. Finally, MUFG Securities EMEA plc boosted its stake in Xylem by 608.1% during the fourth quarter. MUFG Securities EMEA plc now owns 32,990 shares of the industrial products company's stock worth $4,493,000 after buying an additional 28,331 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on XYL shares. Stifel Nicolaus cut their price objective on shares of Xylem from $163.00 to $159.00 and set a "buy" rating on the stock in a research report on Wednesday, April 29th. Oppenheimer dropped their price target on shares of Xylem from $160.00 to $158.00 and set an "outperform" rating for the company in a research note on Wednesday, April 29th. CLSA upgraded shares of Xylem to a "hold" rating in a report on Thursday, June 25th. Citigroup reduced their price objective on shares of Xylem from $174.00 to $168.00 and set a "buy" rating on the stock in a research report on Wednesday, April 29th. Finally, UBS Group raised their price objective on shares of Xylem from $132.00 to $133.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $153.31.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm's stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares of the company's stock, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director directly owned 27,209 shares of the company's stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their position. The SEC filing for this purchase provides additional information. 0.32% of the stock is owned by insiders.

Xylem Stock Performance

Shares of Xylem stock opened at $122.96 on Monday. The stock's fifty day moving average is $113.23 and its two-hundred day moving average is $123.37. The company has a market capitalization of $29.23 billion, a PE ratio of 30.59, a price-to-earnings-growth ratio of 1.75 and a beta of 1.03. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27.

Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The business's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period last year, the company earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, analysts expect that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. The ex-dividend date was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. Xylem's dividend payout ratio (DPR) is presently 42.79%.

Xylem Profile

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.